Translational medicine in neuro-oncology: opportunities and challenges

AndrewAlbrecht,Yong-zhiWang,MinLi*

转化医学研究 ›› 2012, Vol. 2 ›› Issue (4) : 4 -6.

PDF (222KB)
转化医学研究 ›› 2012, Vol. 2 ›› Issue (4) : 4 -6. DOI: 10.3868/j.issn.2095-154x.2012.04.001EN
专题—转化神经科学

Translational medicine in neuro-oncology: opportunities and challenges

    AndrewAlbrecht,Yong-zhiWang,MinLi*
作者信息 +

Translational medicine in neuro-oncology: opportunities and challenges

Author information +
文章历史 +
PDF (227K)

摘要

Glioblastoma Multiforme (GBM) is the most lethal form of all primary brain tumors, due to its broadly mutated and highly variable set of deregulated signaling pathways. Utilizing the wealth of gene and microRNA profiling information to guide therapeutic options would drastically improve the clinician’s ability to diagnose and effectively treat brain tumor. Personalized molecular targeting of oncogenic signaling pathways in aggressive metastatic brain tumors such GBM is still in its infancy. This article discusses how further study into genotype-specific molecular targeted chemotherapy is neededto efficiently translate genomic information into a more effective treatment against this deadly disease.

关键词

translational medicine / brain tumor

Key words

引用本文

引用格式 ▾
Translational medicine in neuro-oncology: opportunities and challenges[J]. 转化医学研究, 2012, 2(4): 4-6 DOI:10.3868/j.issn.2095-154x.2012.04.001EN

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

AI Summary AI Mindmap
PDF (222KB)

227

访问

0

被引

详细

导航
相关文章

AI思维导图

/